Global injectable focus Vitalis is a transnational pharmaceutical manufacturer with seven GMP-certified production plants across Colombia, Mexico, and Chile and a presence in 20 countries. This suggests opportunities in cross-border supply agreements, regulatory-compliant manufacturing partnerships, and centralized quality systems for multinational customers seeking reliable injectable medication production.

Safety leadership The company is recognized as a pioneer in safe drug identification to prevent medication errors and holds the George DiDomizio Award from ISMP. Leverage this differentiator to target hospital systems and distributors prioritizing patient safety programs, value-based procurement, and collaborations around traceability and pharmacovigilance solutions.

Manufacturing excellence With GMP-certified facilities and a focus on injectables, Vitalis could scale contract manufacturing for sterile products, fill-finish capacity, and supply for generic or regional brands. Potential sales angles include CDMO services, capacity planning, and quality/ compliance packages for Asia and Latin America markets.

Regional footprints Operational presence in major Latin American hubs plus Asia indicates momentum in emerging markets. This opens doors for regional distribution partnerships, supply chain optimization services, and regulatory onboarding support for new markets seeking reliable injectable manufacturers.

Visibly scalable credentials GMP certification and international recognition position Vitalis as a trusted supplier. Use these credentials to pursue enterprise deals with mid- to large-sized pharma companies, hospital systems, and wholesale networks seeking partners with robust quality controls, global reach, and patient-safety-focused operation.